155 related articles for article (PubMed ID: 17431111)
1. Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer.
Nahari D; Satchi-Fainaro R; Chen M; Mitchell I; Task LB; Liu Z; Kihneman J; Carroll AB; Terada LS; Nwariaku FE
Mol Cancer Ther; 2007 Apr; 6(4):1329-37. PubMed ID: 17431111
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of the angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) for human anaplastic thyroid carcinoma in nude mice.
Hama Y; Shimizu T; Hosaka S; Sugenoya A; Usuda N
Exp Toxicol Pathol; 1997 Aug; 49(3-4):239-47. PubMed ID: 9314059
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
Gervaz P; Scholl B; Padrun V; Gillet M
Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
[TBL] [Abstract][Full Text] [Related]
5. TNP-470 promotes initial vascular sprouting in xenograft tumors.
Huang J; Frischer JS; New T; Kim ES; Serur A; Lee A; Kadenhe-Chiwishe A; Pollyea DA; Yokoi A; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
Mol Cancer Ther; 2004 Mar; 3(3):335-43. PubMed ID: 15026554
[TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
[TBL] [Abstract][Full Text] [Related]
8. [Implication of vascular endothelial growth factor (VEGF) in human head and neck cancer].
Ueno Y
Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):163-70. PubMed ID: 16615431
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470.
Mori J; Haisa M; Naomoto Y; Takaoka M; Kimura M; Yamatsuji T; Notohara K; Tanaka N
Jpn J Cancer Res; 2000 Jun; 91(6):643-50. PubMed ID: 10874218
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo.
Singh Y; Shikata N; Kiyozuka Y; Nambu H; Morimoto J; Kurebayashi J; Hioki K; Tsubura A
Breast Cancer Res Treat; 1997 Aug; 45(1):15-27. PubMed ID: 9285113
[TBL] [Abstract][Full Text] [Related]
12. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
[TBL] [Abstract][Full Text] [Related]
13. TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model.
Cernaianu G; Frank S; Erbstösser K; Leonhardt S; Cross M; McIvor Z; Scholz G; Dansranjavin T; Celik I; Tannapfel A; Wittekind C; Troebs RB; Rothe K; Bennek J; Hauss J; Witzigmann H
Int J Colorectal Dis; 2006 Mar; 21(2):143-54. PubMed ID: 15937694
[TBL] [Abstract][Full Text] [Related]
14. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.
Jia L; Zhang MH; Yuan SZ; Huang WG
World J Gastroenterol; 2005 Jan; 11(3):447-50. PubMed ID: 15637766
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
Shishido T; Yasoshima T; Denno R; Mukaiya M; Sato N; Hirata K
Jpn J Cancer Res; 1998 Sep; 89(9):963-9. PubMed ID: 9818033
[TBL] [Abstract][Full Text] [Related]
17. Effects of TNP-470 on proliferation and apoptosis in human colon cancer xenografts in nude mice.
Huang ZH; Fan YF; Xia H; Feng HM; Tang FX
World J Gastroenterol; 2003 Feb; 9(2):281-3. PubMed ID: 12532448
[TBL] [Abstract][Full Text] [Related]
18. Reversal of TNP-470-induced endothelial cell growth arrest by guanine and guanine nucleosides.
Hines J; Ju R; Dutschman GE; Cheng YC; Crews CM
J Pharmacol Exp Ther; 2010 Sep; 334(3):729-38. PubMed ID: 20571059
[TBL] [Abstract][Full Text] [Related]
19. Effect of nitroxoline on angiogenesis and growth of human bladder cancer.
Shim JS; Matsui Y; Bhat S; Nacev BA; Xu J; Bhang HE; Dhara S; Han KC; Chong CR; Pomper MG; So A; Liu JO
J Natl Cancer Inst; 2010 Dec; 102(24):1855-73. PubMed ID: 21088277
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of the angiogenesis inhibitor TNP-470 on murine lymphoma/leukemia cells in vivo and in vitro.
Norén-Nyström U; Eriksson M; Eriksson B; Roos G; Bergh A; Holmberg D
Exp Hematol; 2003 Feb; 31(2):143-9. PubMed ID: 12591279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
